Janine Maenza, MD
- Clinical Associate Professor
- Clinic Director, UW/FHCRC HIV Vaccine Trials Unit
- Medical Director, UW Primary Infection Clinic
Dr. Maenza works as a clinical researcher at the UW Primary Infection Clinic and the UW/FHCRC HIV Vaccine Trials Unit. Her work involves seeing research study participants with early HIV infection and volunteers who enroll in clinical trials of preventative HIV vaccines.
Stekler JD, Wellman R, Holte S, Maenza J
, et al. Are there benefits to starting HAART during primary HIV infection? Conclusions from the Seattle Primary Infection Cohort vary by control group. Int J STD AIDS.
2012; 23(3): 201-6.
Rosenberg ES, Graham BS, Chan ES, Bosch R, Stocker V, Maenza J
, et al. Safety and immunogenicity of therapeutic DNA vaccination in individuals treated with antiretroviral therapy during acute/early HIV-1 infection. PlosOne.
2010; 5(5): e10555.
Chun TW, Justement JS, Murray D, Hallahan CW, Maenza J
, et al. Rebound of plasma viremia following cessation of antiretroviral therapy despite profoundly low levels of HIV reservoir: implications for eradication. AIDS
. 2010; 24 :2803-8.
Mark KE, Maenza J
, Garcia D, et al. Educating community medical providers about HIV vaccine induced seropositivity. Retrovirology
. 2009; 6(Suppl 3): P199.
Stekler J, Maenza J
, Stevens CE, et al. Screening for acute HIV infection: lessons learned. Clin Infect Dis
Chun TW, Justement JS, Moir S, Hallahan C, Maenza J
,et al. Decay of the HIV reservoir in patients receiving antiretroviral therapy for extended periods: implications for eradication of virus.
J Infect Dis